Anaplastic Large Cell Lymphoma, ALK-Negative

Also known as: Anaplastic Large Cell Lymphoma, ALK-negative

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00493Cefotaxime1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Completed1
DB00997Doxorubicin1 / 2Active Not Recruiting1
DB00997Doxorubicin1 / 2Completed1
DB00773Etoposide1 / 2Active Not Recruiting1
DB01590Everolimus1 / 2Completed1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB00860Prednisolone1 / 2Completed1
DB00635Prednisone1 / 2Active Not Recruiting1
DB14546Sulfate ion1 / 2Active Not Recruiting1
DB00541Vincristine1 / 2Active Not Recruiting1
DB00541Vincristine1 / 2Completed1
DB08870Brentuximab vedotin2Recruiting1
DB00493Cefotaxime2Recruiting1
DB00515Cisplatin2Active Not Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB00997Doxorubicin2Active Not Recruiting1
DB00997Doxorubicin2Recruiting1
DB00773Etoposide2Recruiting1
DB00441Gemcitabine2Active Not Recruiting1
DB00959Methylprednisolone2Active Not Recruiting1
DB00860Prednisolone2Active Not Recruiting1
DB00635Prednisone2Recruiting1
DB14922Tislelizumab2Recruiting1
DB00541Vincristine2Active Not Recruiting1